Ventas (NYSE: VTR) reported Q3 EPS of $0.44, $0.01 worse than the analyst estimate of $0.45. Revenue for the quarter came in at $899.93 million versus the consensus estimate of $882.25 million.

• Earnings Growth and Enhanced Financial Strength
• Property Level Growth Across All Segments; Updated and Improved 2017 Guidance
• Over $600 Million of Strategic Dispositions with Gains Exceeding $500 Million
• Expansion of Attractive University-Based Life Science Business

For earnings history and earnings-related data on Ventas (VTR) click here.